Upexi, Inc.
UPXIFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Upexi, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Jun 30, 2025. The latest insider filing shown is dated Dec 23, 2025.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Upexi, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-07-11 · MARSHALL ALLAN: Larger than 35 of the 37 other insider purchases of Common Stock on file. SEC filing
- 2025-04-17 · MARSHALL ALLAN: Larger than all 37 other insider purchases of Common Stock on file. SEC filing
- 2025-04-17 · Salkind Gene: Larger than 36 of the 37 other insider purchases of Common Stock on file. SEC filing
- 2022-03-30 · Salkind Gene: Larger than 34 of the 37 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-07-11–2025-07-16: 5 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2025-04-17–2025-04-17: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-23 | MARSHALL ALLAN · Chief Executive Officer | Common Stock | P — Open market or private purchase | +50,000 | 1.80 | SEC filing |
| 2025-12-16 | MARSHALL ALLAN · Chief Executive Officer | Common Stock | P — Open market or private purchase | +50,000 | 2.07 | SEC filing |
| 2025-12-15 | MARSHALL ALLAN · Chief Executive Officer | Common Stock | P — Open market or private purchase | +100,000 | 2.07 | SEC filing |
| 2025-11-20 | Salkind Gene · Director | Common Stock | P — Open market or private purchase | +50,000 | 2.55 | SEC filing |
| 2025-11-17 | Salkind Gene · Director | Common Stock | P — Open market or private purchase | +100,000 | 2.65 | SEC filing |
| 2025-11-17 | Salkind Gene · Director | Common Stock | P — Open market or private purchase | +100,000 | 2.81 | SEC filing |
| 2025-07-22 | Dugan Lawrence · Director | Common Stock | P — Open market or private purchase | +4,000 | 7.50 | SEC filing |
| 2025-07-16 | Dugan Lawrence · Director | Common Stock | P — Open market or private purchase | +10,000 | 5.70 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-10-01 | Norstrud Andrew James · Chief Financial Officer | Common Stock | A — Grant, award, or other acquisition | +240,000 | SEC filing |
| 2025-10-01 | MARSHALL ALLAN · Chief Executive Officer | Common Stock | A — Grant, award, or other acquisition | +1,600,000 | SEC filing |
| 2025-07-16 | Dugan Lawrence · Director | Common Stock | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2025-07-16 | Rudick Brian Benjamin · CSO | Common Stock | A — Grant, award, or other acquisition | +400,000 | SEC filing |
| 2025-07-16 | Williams Thomas Charles · Director | Common Stock | A — Grant, award, or other acquisition | +50,000 | SEC filing |
| 2025-07-16 | Salkind Gene · Director, 10% owner | Common Stock | A — Grant, award, or other acquisition | +150,000 | SEC filing |
| 2025-07-16 | MARSHALL ALLAN · Chief Executive Officer | Common Stock | A — Grant, award, or other acquisition | +1,200,000 | SEC filing |
| 2025-07-16 | Salkind Gene · Director, 10% owner | Common Stock | A — Grant, award, or other acquisition | +50,000 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.